Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Dal Pan GJ"'
Publikováno v:
Clinical Pharmacology & Therapeutics; Jul2016, Vol. 100 Issue 1, p102-108, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dal Pan GJ, Temple R
Publikováno v:
Archives of Internal Medicine; 1/9/2012, Vol. 172 Issue 1, p74-75, 2p
Autor:
Bradley MC; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Rai A; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA., Cosgrove A; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA., Perez-Vilar S; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA., Fuller C; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA., Rosen E; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA., Eworuke E; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Epidemiology and Drug Safety Team, Real World Solutions, IQVIA, Durham, North Carolina, USA., McLean LE; HCA Healthcare, Nashville, Tennessee, USA., Guy JS; HCA Healthcare, Nashville, Tennessee, USA., Poland RE; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA.; HCA Healthcare, Nashville, Tennessee, USA., Sands KE; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA.; HCA Healthcare, Nashville, Tennessee, USA., Dal Pan GJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Oct; Vol. 33 (10), pp. e70018.
Autor:
Mahesri M; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA, 02120, USA. mmahesri@mgh.harvard.edu., Sarpatwari A; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA, 02120, USA.; Program on Regulation, Therapeutics, and Law, Boston, MA, USA., Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA, 02120, USA., Lii J; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA, 02120, USA., Lee SB; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA, 02120, USA., Toyserkani GA; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., LaCivita C; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Zhou EH; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Dal Pan GJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Kesselheim AS; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA, 02120, USA.; Program on Regulation, Therapeutics, and Law, Boston, MA, USA., Bykov K; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street (Suite 3030), Boston, MA, 02120, USA.
Publikováno v:
Drug safety [Drug Saf] 2024 Sep; Vol. 47 (9), pp. 909-919. Date of Electronic Publication: 2024 May 16.
Autor:
Matheny ME; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.; Geriatric Research Education and Clinical Care Service, Tennessee Valley Healthcare System VA, Nashville., Yang J; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Smith JC; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee., Walsh CG; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee., Al-Garadi MA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee., Davis SE; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee., Marsolo KA; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina., Fabbri D; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Computer Science, Vanderbilt University, Nashville, Tennessee., Reeves RR; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.; Geriatric Research Education and Clinical Care Service, Tennessee Valley Healthcare System VA, Nashville., Johnson KB; Department of Epidemiology and Informatics, University of Pennsylvania, Philadelphia.; Department of Pediatrics, University of Pennsylvania, Philadelphia., Dal Pan GJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Ball R; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Desai RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2428276. Date of Electronic Publication: 2024 Aug 01.